300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Oceania
LATAM
Oman
Puerto Rico
Poland
Andorra
Guernsey
Cameroon
Sudan
Colombia
Armenia
China
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Canada
Paraguay
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
Ireland
India
Germany
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database

China Science and Technology Innovation

VC Fund

China Science and Technology Innovation is a VC fund focused on Manufacturing and Energy. China Science and Technology Innovation operates as an investment firm.

Total investments:
10
Last investment:
Lead investor:
10%

Last updated:

Industries China Science and Technology Innovation invests in

ManufacturingEnergyElectronicsBiotechnologySemiconductor

Stages China Science and Technology Innovation invests in

Series ASeedSeries BAngelSeries C

Countries China Science and Technology Innovation invests in

ChinaJapan

Round sizes

Seed $15M–$16MSeries A $31M–$251MSeries B $31M–$251M

Round size

Seed
$15M–$16M
Series A
$31M–$251M
Series B
$31M–$251M

Investment Focus

Industry

  • Manufacturing 3 (30%)
  • Energy 2 (20%)
  • Electronics 2 (20%)
  • Biotechnology 2 (20%)
  • Semiconductor 2 (20%)
See all 16 industries →

Stage

  • Series A 4 (40%)
  • Seed 2 (20%)
  • Series B 2 (20%)
  • Angel 1 (10%)
  • Series C 1 (10%)

Country

  • China 9 (90%)
  • Japan 1 (10%)

Investments

CompanyDescriptionRoundLinks
Kaixinhong
RedRISC is a cutting edge semiconductor enterprise focused on high end chip design services and open source hardware ecosystems. Operating as the dedicated industrialization and commercial platform for the Beijing Open Source Chip Research Institute, the company leverages the high profile Xiangshan open source processor architecture to develop highend computing solutions. $14.8M / Seed / Aug 11, 2026
Bengbengyu is a freshwater fish breeding manufacturer that engages in product nursery, breeding, and processing of aquatic products. Series A / May 15, 2024
Zhaohuang New Energy Zhaohuang New Energy
Zhaohuang New Energy manufactures metal lithium anode products that are used in the used in the fields of next-generation solid-state lithium batteries, lithium-sulfur batteries, and lithium-air batteries. Angel / Jul 17, 2023
Yanming Biology Yanming Biology
Pyrotech pharmaceuticals is a biotechnology company that focuses om development for drugs for the treatment of inflammation and tumors. $96.8M / Series A / Jul 10, 2023
Lechun Biology is an enterprise engaged in disposable products and leak detection equipment in the biotechnology and pharmaceutical industries. The company develops and produces disposable biopharmaceutical process equipment and consumables. The products are used for the storage, transportation, filling and leak detection of various samples inbiosimilars, vaccines and other biopharmaceutical processes. The core product is a disposable storage bag. Recently completed B+ round of financing. This round of financing will be mainly used for the development of a number of innovative new products, the establishment of a US R&D center, the integration of the upstream industrial chain, the securing of the supply chain, and the expansion of the R&D market operation team at home and abroad. Series C / Jan 12, 2023
Gokin Solar
Guangdong Gaojing Solar Energy Technology is a solar energy technology. $251.2M / Series A / Apr 13, 2022
Xinling Pharmaceutical is an innovative transdermal preparation platform company. $15.7M / Seed / Mar 18, 2022
NewRadioTech focuses on the silicon and system solutions for wireless communication and positioning systems. $31.4M / Series A / Jan 29, 2022
Vastai Technologies is focused on developing AI chips for the optimization of computer vision and video processing. $251M / Series B / Dec 20, 2021
Akon health is an operation and management organization of prescription drugs for chronic diseases, which integrates prescription drug management, chronic disease management, hospital prescription circulation, e-commerce operation, and out-of-hospital prescription increment. It focuses on providing pharmaceutical service and care for patients withchronic diseases who leave the hospital, and providing channel expansion, product increment, and patient data management of out-of-hospital prescription drugs for pharmaceutical enterprises. $30.7M / Series B / Mar 17, 2021

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Oceania
LATAM
Oman
Puerto Rico
Poland
Andorra
Guernsey
Cameroon
Sudan
Colombia
Armenia
China
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Canada
Paraguay
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
Ireland
India
Germany
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does China Science and Technology Innovation invest in?

China Science and Technology Innovation invests primarily in Manufacturing, Energy and Electronics startups, most often at Series A and Seed stage. Most of the 10 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is China Science and Technology Innovation's check size?

China Science and Technology Innovation typically joins rounds of $15M–$16M at Seed, $31M–$251M at Series A and $31M–$251M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds China Science and Technology Innovation participates in.

When did China Science and Technology Innovation last invest?

The most recent investment recorded for China Science and Technology Innovation closed in Aug 2026. Shizune tracks 10 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
China Science and Technology Innovation Find emails